From February 4, 2024 to March 31, 2024, the company has repurchased 8,806,030 shares, representing 3.81% for CNY 75.3 million. With this, the company has completed the repurchase of 8,806,030 shares, representing 3.81% for CNY 75.3 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.05 CNY | -2.99% | -6.44% | -11.32% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.32% | 352M | |
+15.41% | 78.65B | |
+9.32% | 8.94B | |
-10.76% | 5.16B | |
+54.31% | 4.85B | |
+11.19% | 4.19B | |
-22.37% | 2.32B | |
+12.41% | 2.29B | |
-30.09% | 2.19B | |
+20.63% | 2.19B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.